Vuno supplies X-ray imaging solution to Mongolia with WHO support www.koreabiomed.com
Vuno, a company developing medical software, said Tuesday that it would supply its artificial intelligence (AI)-based chest X-ray solution, VUNO Med-Chest X-ray, to the National Center for Communicable Diseases of Mongolia.
Mongolia’s health authorities requested the World Health Organization (WHO) to purchase Vuno’s AI solutions to meet the country’s increasing demand for lung and chest diseases, including the Covid-19, and introduced it to the nation.
The VUNO Med-Chest X-ray can detect abnormal findings, such as nodule, fibrosis, pneumothorax in chest images, assisting healthcare providers to lesions in a clear image.
The new product helps medical experts improve the diagnostic efficacy by providing an initial reading of the patient’s chest images and report abnormal findings, allowing the healthcare givers to quickly follow-up with the lesions, the company said.
Mongolia’s National Center for Communicable Diseases was established in 2001 to manage, prevent, monitor, diagnose, and treat patients with infectious diseases in the country. It conducted the clinical trials of Vuno’s AI-based solution for sexually transmitted diseases in 2017, and introduced it to the country’s hospitals.
Vuno won the product's approval from the Ministry of Food and Drug Safety in August 2019 by proving its excellent sensitivity and specificity for detecting five abnormal symptoms in clinical trials, the company said.
It also has won the Conformite Europeenne (CE) certification, which allows European countries to use the product.
“We are glad to supply VUNO Med-Chest X-ray solution to the Mongolian National Center for Communicable Diseases, which has maintained a long relationship with us,” Vuno CEO Kim Hyun-jun said. “Vuno will keep making efforts to help more countries in need of healthcare.”
Published Date:2021-03-10